Paul-Ehrlich-Institut

Go to:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Other Medicinal Products for Human Use

Medicines for which the Paul-Ehrlich-Institut is responsible, but which are not assigned to a particular group of medicines.

Search results 26 to 30 from a total of 30

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Kind of Vac­cine Li­cense Num­ber Li­cense Date Further Information

Broncho-Vaxom Kinder, Kapseln

Multibacterial Lysat

Prophylaxe und Therapie rezidivierende Infekte der oberen Luftwege

MPA Pharma GmbH

 weitere 63a/97 13.10.1997

Broncho-Vaxom Erwachsene, Kapseln

Multibacterial Lysat

Pro­phylaxe und Therapie rezi­divierende Infekte der oberen Luft­wege

MPA Pharma GmbH

 weitere 62a/97 13.10.1997

Broncho-Vaxom Erwachsene, Kapseln

Multibacterial Lysat

Prophylaxe und Therapie rezidivierende Infekte der oberen Luftwege

Eurim-Pharm Arzneimittel GmbH

 weitere 182a/95 29.11.1996

PharmNet.Bund

Broncho-Vaxom Erwachsene, Kapseln

Multibacterial Lysat, Bakterienextrakt

Prophylaxe und Therapie rezi­divierende Infekte der oberen Luft­wege

Pharma Gerke Arzneimittelvertriebs GmbH

 weitere PEI.H.11775.01.1 16.10.2015

PharmNet.Bund

Tuberkulin PPD RT23 AJV (2 T.E.)

Tuberkulose-Diagnostikum

AJ Vaccines A/S, Dänemark

weitere PEI.H.03306.01.1 08.08.2005

PharmNet.Bund

Tuberkulinversorgung in Deutschland – Verfügbarkeit möglicher Alternativen

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 519 in BAnz AT 26.07.2024 B6.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 26.07.2024